Promising prostate cancer combo trial halted early after just one patient
Disease control
Terminated
This study tested whether giving a targeted radiation drug (LuPSMA) alone or with an immunotherapy (ipilimumab) before prostate removal surgery is safe and feasible for men with very high-risk prostate cancer. Only one participant was enrolled before the trial was terminated, so …
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Essen • Aim: Disease control
Last updated May 14, 2026 12:02 UTC